Case File
efta-efta00379063DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00379063
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To:
Subject: Re: the One First Class Seat is showing available again on 2:10pm flight
Date: Fri, 22 Nov 2013 20:36:35 +0000
ask to speak with special services of air france
On Fri, Nov 22, 2013 at 9:30 PM,
> wrote:
I called AF and they cannot do anything with the ticket you are currently holding... it is one reservation for 2
people...all AF could do is book you new tickets at the same price tag Amex has given me for first and biz...I
am on with Amex and being told the rules of this 2 for 1 ticket are the rules...you must both travel in the same
class and that is it. I am on hold with Amex now so the rep can speak with the manager on help desk to see
what we can do...
I keep asking if the 8:10am might have 2 seats available also...and we can't wait list any of these flights
because it is less than 24 hours prior to the flight.
On Nov 22, 2013, at 2:55 PM, Jeffrey Epstein <[email protected]> wrote:
ask american express if we can take this seat and waitlist the other. or ask to speak to an air france special
service rep. it makes no sense that it would cost more for her to downgrade.
On Fri, Nov 22, 2013 at 8:52 PM,
> wrote:
First Class Seat showing available a
you want me to purchase you the one first class seat on the
2:10pm flight at $11,383.80 and
a ticket in biz or coach (Biz ticket: $6483.80
Coach: $3228.60)
You would get a credit for around $9099 for the unused 2 for 1 deal...
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00379063
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00379064
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.